Evaluation of Subconjunctival Triamcinolone for Nonnecrotizing Anterior Scleritis

Subconjunctival corticosteroid injection in eyes that failed other therapies is effective, reduces dependence on systemic medications, and did not result in scleral necrosis over a median follow-up period of 29 months.